Latest News

Sphere Medical – Successful Healthcare IPO

Sphere Medical (AIM: SPHR) commenced trading on AIM on 17 November, 2011 following successfully raising £14 million.

Sphere is a UK based medical device company completing the development of a range of in vitro diagnostic products designed to provide significant improvements in patient management in a number of hospital specialities. Sphere’s products are expected to allow near real time measurement of blood gases, various electrolytes and drug levels with laboratory accuracy, at the patient’s bedside. This information can be used in a wide range of medical applications and is intended to enable faster clinical decision making and consequently to improve the management of patients.

Sphere is represented by Tim Anderson, Lisa Baderoon and Jessica Fontaine.